Rewriting Life

Cheap Genes

  • February 21, 2012

A new benchtop DNA sequencer will allow medical clinics to sequence a patient’s entire genome in a day. The system uses this disposable semiconductor chip, which has an array of microscopic wells containing known DNA templates on its upper surface. Fragments of a patient’s genome are washed over these wells, and matches between a template and the patient’s DNA trigger electronic sensors attached to the well. The chip and required reagents together cost $1,000 per genome. The sequencer will allow doctors, as part of a patient’s normal care, to test for genetic conditions or assess whether the patient is likely to respond to a particular drug.

Product: Ion Proton Sequencer
Cost: $149,000
Availability: Mid-2012
Source: www.lifetechnologies.com
Companies: Life Technologies

Uh oh–you've read all of your free articles for this month.

Insider Premium
$179.95/yr US PRICE

More from Rewriting Life

Reprogramming our bodies to make us healthier.

Want more award-winning journalism? Subscribe to Insider Premium.
  • Insider Premium {! insider.prices.premium !}*

    {! insider.display.menuOptionsLabel !}

    Our award winning magazine, unlimited access to our story archive, special discounts to MIT Technology Review Events, and exclusive content.

    See details+

    What's Included

    Bimonthly home delivery and unlimited 24/7 access to MIT Technology Review’s website.

    The Download. Our daily newsletter of what's important in technology and innovation.

    Access to the Magazine archive. Over 24,000 articles going back to 1899 at your fingertips.

    Special Discounts to select partner offerings

    Discount to MIT Technology Review events

    Ad-free web experience

    First Look. Exclusive early access to stories.

    Insider Conversations. Listen in as our editors talk to innovators from around the world.

/
You've read all of your free articles this month. This is your last free article this month. You've read of free articles this month. or  for unlimited online access.